Evidence map›Paper›PMID 30288334›Full record

ReviewHepatology, medicine and policy2018

Strategies for achieving viral hepatitis C micro-elimination in the Netherlands.

P A M Kracht, J E Arends, K J van Erpecum, A Urbanus, J A Willemse, A I M Hoepelman, E A Croes

Abstract readReview
In one paragraph

Review in Hepatology, medicine and policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands.The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
  10. Review
  11. Elimination of Hepatitis C in Portugal: An Urban Legend?GE Portuguese journal of gastroenterology · 2020
    Review
  12. Article
  13. Hepatitis C elimination: a Public Health Perspective.Current treatment options in gastroenterology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

P A M KrachtDepartment of Internal medicine and Infectious disease, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0002-5794-9386
J E ArendsDepartment of Internal medicine and Infectious disease, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands.
K J van ErpecumDepartment of Gastroenterology and Hepatology, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands.
A Urbanus3Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
J A WillemseDutch Liver Patient Association (NLV), Hoogland, the Netherlands.
A I M HoepelmanDepartment of Internal medicine and Infectious disease, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands.
E A Croes5Netherlands Institute of Mental Health and Addiction (Trimbos Institute), Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Netherlands is striving to achieve national elimination of the hepatitis C virus (HCV) as one of the first countries worldwide. The favorable HCV epidemiology with both low prevalence and incidence, together with access to care and treatment, present excellent conditions to further build on towards this objective. The Dutch national plan on viral hepatitis, introduced in 2016, defines targets in the HCV healthcare cascade and provides a structural framework for the development of elimination activities. Since many different stakeholders are involved in HCV care in the Netherlands, focus has been placed on micro-elimination initiatives as a pragmatic and efficient approach. These numerous micro-eliminations projects have brought the Netherlands closer to HCV elimination. In the near future, efforts specifically have to be made in order to optimize case-finding strategies and to successfully accomplish the nationwide implementation of the registration and monitoring system of viral hepatitis mono-infections, before this final goal can be reached. The upcoming years will then elucidate if the Dutch' hands on approach has resulted in sufficient progress against HCV and if the Netherlands will lead the way towards nationwide HCV elimination.

Indexed as

Hepatitis C virusHep-CORE, HCV cascade of careMicro-elimination

Identifiers

PMID30288334
PMCPMC6162944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.